Habtamu Milkias Wolde: New Insights into Stroke and Traumatic Brain Injury from Global Burden of Disease Data
Habtamu Milkias Wolde, Postdoctoral Researcher at Sungkyunkwan University, shared on LinkedIn:
”Below I also share two recently published studies by our research group at SKKU on Stroke and Traumatic Brain Injury using Global Burden of Diseases (GBD) data.
These studies provide updated estimates of disease burden and describe key patterns and disparities across populations using standardized global health metrics.
Please find the links to these interesting studies.”
Title 1: Stroke burden and risk factor disparities across East Asia, Western Europe, and North America, 1990-2023, with forecasts to 2050
Authors: Youngoh Bae, Minyoung Kim, Habtamu Milkias Wolde, Jae June Dong, Hyeongwoo Song, Seung Won Lee

Title 2: Severity-Specific Trends and Future Projections of Traumatic Brain Injury in the Americas, 1990–2050
Authors: Habtamu Milkias Wolde, Ali Raza, Minyoung Kim, Hyeongwoo Song, Hyun Yong Koh, Youngoh Bae, Seung Won Lee

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 13:27Shirley D’Sa: Connecting European and Mayo Clinic Experts in MGCS Research and Care
-
Nov 13, 2026, 13:20Josie Sirna: Representing the Thalassemia Community at Canada’s Rare Disease Conference in Halifax
-
Nov 13, 2026, 13:14Annalisa Ruggeri: 18 Years in Haematology – Celebrating a Journey at San Raffaele
-
Nov 13, 2026, 13:08Did You Know That 20–30% of Female Hemophilia Carriers Experience Bleeding Symptoms? – Haemophilia Foundation Australia
-
Nov 13, 2026, 12:12Issac Cheong: POCUS Detection of IVC Filter Thrombosis With Right Atrial Extension
-
Nov 13, 2026, 11:57Dianne E. van der Wal: Red Blood Cell Engineering and the Role of Cytokine Glycosylation
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy